The Pharmaceutical Global Value Chain: Participation and Opportunities for Latin America and the Caribbean

Author
Frederick, Stacey
Date issued
Sep 2025
Editor
García, Pablo M.;
Blyde, Juan S.
Subject
Manufacturing Industry;
Global Value Chain;
Pharmaceutical Industry;
Intellectual Property;
Small Business;
Research and Development
JEL code
F01 - Global Outlook;
F14 - Empirical Studies of Trade;
F23 - Multinational Firms • International Business;
F63 - Economic Development;
L65 - Chemicals • Rubber • Drugs • Biotechnology;
N66 - Latin America • Caribbean
Category
Technical Notes
This report provides an overview of the global pharmaceutical industry, highlighting key trends, the geographic spread of activities, and important firms and stakeholders. It examines the participation of Latin American and Caribbean (LAC) countries in the pharmaceutical industry, identifying opportunities for expansion and areas for improvement. The report discusses the growth in generics and biologics, the impact of demographic and lifestyle changes on demand, and the significant role of research and development (R&D) in bringing new medications to market. It also addresses the challenges faced by the LAC region, such as low adherence to Good Manufacturing Practice (GMP) standards and the need for increased government expenditure on healthcare and drugs. Recommendations include promoting industrial and research parks, fostering research collaborations, and enhancing workforce development to boost the region's pharmaceutical capabilities.
NO